Scarica l'app Stockscreener
572.74
0.18%
-1.05
Pre-mercato:
576.50
3.76
+0.66%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$573.79
Aprire:
$573.35
Volume 24 ore:
1.17M
Relative Volume:
0.59
Capitalizzazione di mercato:
$216.27B
Reddito:
$43.74B
Utile/perdita netta:
$6.58B
Rapporto P/E:
33.09
EPS:
17.3072
Flusso di cassa netto:
$6.11B
1 W Prestazione:
-1.27%
1M Prestazione:
+5.31%
6M Prestazione:
+38.43%
1 anno Prestazione:
+11.68%
Intervallo 1D:
$568.46
$580.45
Intervallo di 1 settimana:
$556.46
$584.33
Portata 52W:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
572.74 | 215.58B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
222.18 | 157.10B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
689.35 | 55.66B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.06 | 40.94B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
217.11 | 37.04B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer - BioSpace
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth - The Globe and Mail
TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner - TradingView
Can Thermo Fisher Scientific Inc. stock sustain institutional interestMarket Risk Analysis & Short-Term High Return Ideas - newser.com
The Bull Case For Thermo Fisher Scientific (TMO) Could Change Following EXENT System Clearance and New Philly Center Opening – Learn Why - Yahoo Finance
Will Thermo Fisher Scientific Inc. (TN8) stock sustain bullish trend into 2025Market Trend Report & Consistent Income Trade Ideas - newser.com
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock behaves in tightening cyclesTrade Exit Summary & Safe Entry Zone Identification - newser.com
Institutions Love These 3 Companies, Should You As Well? - Finviz
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two - PharmTech.com
Thermo Fisher unveils Advanced Therapies Collaboration Centre in US - BioSpectrum Asia
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing* - bastillepost.com
Why Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock signals breakout potential2025 Analyst Calls & AI Driven Stock Reports - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock expanding market penetration2025 Market Outlook & Safe Capital Growth Tips - newser.com
How robust is Thermo Fisher Scientific Inc stock financial positionBreakout Watch & Advanced Swing Trade Entry Plans - newser.com
Is Thermo Fisher Scientific Inc stock supported by strong fundamentalsJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development - BioSpace
Will Thermo Fisher Scientific Inc. (TN8) stock outperform global peersJuly 2025 Action & Long-Term Growth Stock Strategies - newser.com
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs - citybiz
Is Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock attractive for growth funds2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
Why Thermo Fisher chose Philly for its new East Coast collaboration center for biotech startups - The Business Journals
Thermo Fisher targets early-stage CGT bottlenecks with new Philadelphia hub - rdworldonline.com
These 3 Stocks Are Using Buybacks to Signal Market Confidence - Investing.com
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Philadelphia - Contract Pharma
These 3 Stocks Are Using Buybacks to Signal Market Confidence - Finviz
Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga
Thermo Fisher Scientific Digital Transformation Strategy Analysis Report 2025: Accelerators, Incubators, and Other Innovation ProgramsResearchAndMarkets.com - Bluefield Daily Telegraph
Moody’s upgrades Thermo Fisher Scientific to A2, outlook stable - Investing.com
Thermo Fisher Scientific Inc. (NYSE:TMO) Is a Favorite Amongst Institutional Investors Who Own 89% - 富途牛牛
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder - The AI Journal
Thermo Fisher Scientific launches CorEvitas clinical registry in myasthenia gravis - PharmaLive
Will Thermo Fisher Scientific Inc. (TN8) stock split increase liquidityMarket Movement Recap & Risk Controlled Stock Alerts - newser.com
A Closer Look at Thermo Fisher Scientific's (TMO) Valuation After Recent Share Price Strength - simplywall.st
Is Thermo Fisher Scientific Inc. (TN8) stock considered safe havenJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
Can Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock expand revenue streamsTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock supported by strong fundamentalsWeekly Earnings Recap & Real-Time Stock Price Movement Reports - newser.com
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock gains from tech spendingJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
If You Invested $1000 in Thermo Fisher Scientific 10 Years Ago, This Is How Much You'd Have Now - sharewise.com
Is Thermo Fisher Scientific Inc stock in buy zone after pullbackDividend Hike & Daily Chart Pattern Signal Reports - newser.com
Insider Sell: Lisa Britt Sells Shares of Thermo Fisher Scientifi - GuruFocus
Will Thermo Fisher Scientific Inc stock outperform benchmarks2025 Top Decliners & Safe Swing Trade Setups - newser.com
Rx Rundown: Metagenomi, Chiesi, Thermo Fisher Scientific and more - Medical Marketing and Media
Thermo Fisher Scientific Insider Sold Shares Worth $2,756,920, According to a Recent SEC Filing - MarketScreener
Will Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock hit analyst forecastsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Why Thermo Fisher Scientific Inc. (TN8) stock remains top ratedTrade Signal Summary & Risk Controlled Stock Alerts - Fundação Cultural do Pará
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific - Nasdaq
Kimberly-Clark, Thermo Fisher Scientific, Berkshire Hathaway And An Industrial Stock On CNBC's 'Final Trades' - Benzinga
Will Thermo Fisher Scientific Inc. stock recover faster than peersQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
Thermo Fisher Scientific (TMO): Assessing Valuation After a 10% Monthly Share Price Surge - Yahoo Finance
How dovish Fed policy supports Thermo Fisher Scientific Inc. (TN8) stock2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Is Thermo Fisher Scientific Inc. (TN8) stock among top earnings playsJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Fund Update: 127,576 THERMO FISHER SCIENTIFIC (TMO) shares added to First Pacific Advisors, LP portfolio - Quiver Quantitative
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.10%
0.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):